Sabra Health Care REIT, Inc. (SBRA)
NASDAQ: SBRA · Real-Time Price · USD
20.44
+0.18 (0.89%)
Nov 13, 2026, 4:00 PM EST - Market closed
Sabra Health Care REIT Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Rental Revenue | 392.45 | 374.13 | 381.5 | 376.27 | 400.59 | 396.72 |
Other Revenue | 505.1 | 360.81 | 284.18 | 233.26 | 96.31 | -25.8 |
| 924.3 | 775.76 | 702.64 | 644.62 | 531.95 | 388.24 | |
Revenue Growth (YoY | 23.73% | 10.41% | 9.00% | 21.18% | 37.02% | -35.38% |
Property Expenses | 361.29 | 271.11 | 227.09 | 195.25 | 162.61 | 141.2 |
Selling, General & Administrative | 63.17 | 53.71 | 50.07 | 47.47 | 39.57 | 34.67 |
Depreciation & Amortization | 225.69 | 187 | 169.62 | 183.09 | 187.78 | 178.99 |
Provision for Loan Losses | -104.19 | 1.05 | 0.57 | -0.19 | -0.14 | -3.94 |
Total Operating Expenses | 754.35 | 510.77 | 446.21 | 426 | 390.11 | 358.8 |
Operating Income | 169.95 | 265 | 256.43 | 218.62 | 141.84 | 29.44 |
Interest Expense | -116.29 | -112.49 | -114.77 | -112.96 | -105.47 | -98.63 |
Other Non-Operating Income | -0.03 | -3.66 | 0.04 | 2.6 | -1.1 | 0.37 |
EBT Excluding Unusual Items | 53.63 | 148.84 | 141.69 | 108.26 | 35.27 | -68.82 |
Gain (Loss) on Sale of Investments | - | - | - | - | -7.67 | -10.77 |
Gain (Loss) on Sale of Assets | 20.59 | -3.52 | 2.1 | -76.63 | -12.01 | 12.3 |
Total Insurance Settlements | - | 1.7 | 2.2 | - | - | - |
Asset Writedown | -1.09 | -7.32 | -18.47 | -14.33 | -94.04 | -9.5 |
Other Unusual Items | -0.1 | 17.65 | 0.2 | -1.54 | 2.09 | -34.62 |
Pretax Income | 73.04 | 157.35 | 127.72 | 15.76 | -76.36 | -111.41 |
Income Tax Expense | 1.77 | 1.84 | 1.01 | 2 | 1.24 | 1.85 |
Earnings From Continuing Operations | 71.27 | 155.51 | 126.71 | 13.76 | -77.61 | -113.26 |
Minority Interest in Earnings | 0.24 | 0.1 | - | - | - | - |
Net Income | 71.51 | 155.61 | 126.71 | 13.76 | -77.61 | -113.26 |
Net Income to Common | 71.51 | 155.61 | 126.71 | 13.76 | -77.61 | -113.26 |
Net Income Growth | -59.16% | 22.80% | 821.14% | - | - | - |
Basic Shares Outstanding | 252 | 241 | 233 | 231 | 231 | 219 |
Diluted Shares Outstanding | 256 | 244 | 236 | 233 | 231 | 219 |
Shares Change | 6.23% | 3.58% | 1.40% | 0.80% | 5.42% | 5.70% |
EPS (Basic) | 0.28 | 0.64 | 0.54 | 0.06 | -0.34 | -0.52 |
EPS (Diluted) | 0.28 | 0.64 | 0.54 | 0.06 | -0.34 | -0.52 |
EPS Growth | -61.34% | 18.52% | 807.61% | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share | 1.200 | 1.200 | 1.200 | 1.200 | 1.200 | 1.200 |
Dividend Growth | 0% | 0% | 0% | 0% | 0% | -11.11% |
Operating Margin | 18.39% | 34.16% | 36.49% | 33.91% | 26.66% | 7.58% |
Profit Margin | 7.74% | 20.06% | 18.03% | 2.13% | -14.59% | -29.17% |
EBITDA | 390.77 | 447.11 | 421.19 | 395.89 | 323 | 221.94 |
EBITDA Margin | 42.28% | 57.64% | 59.94% | 61.41% | 60.72% | 57.17% |
D&A For Ebitda | 220.81 | 182.12 | 164.76 | 177.27 | 181.16 | 192.5 |
EBIT | 169.95 | 265 | 256.43 | 218.62 | 141.84 | 29.44 |
EBIT Margin | 18.39% | 34.16% | 36.49% | 33.91% | 26.66% | 7.58% |
Funds From Operations (FFO) | 283.33 | 360.87 | 321.61 | 296.5 | 295.88 | 253.22 |
FFO Per Share | 1.11 | 1.48 | 1.36 | 1.27 | 1.28 | 1.15 |
Adjusted Funds From Operations (AFFO) | 409.72 | 361.57 | 338.19 | 311.33 | 333.02 | 297.14 |
AFFO Per Share | 1.60 | 1.47 | 1.43 | 1.33 | 1.43 | 1.35 |
FFO Payout Ratio | 106.86% | 80.22% | 87.11% | 93.57% | 93.67% | 103.83% |
Effective Tax Rate | 2.42% | 1.17% | 0.79% | 12.71% | - | - |
Revenue as Reported | 919.09 | 774.63 | 703.24 | 647.51 | 624.81 | 569.55 |